ICICI Direct has refrained from issuing a traditional recommendation for the Corona Remedies initial public offering, designating it as "UNRATED" in their latest assessment.

Motilal Oswal Financial Services has issued a Buy recommendation for Aurobindo Pharma Ltd.

Axis Securities Limited has issued a BUY recommendation for Biocon Limited, positioning the pharmaceutical giant as their "Pick of the Week" with a compelling investment thesis.

Hem Securities Research has issued a decisive "SUBSCRIBE" recommendation for Sudeep Pharma Limited's initial public offering, valuing the company at a price band of Rs 563-593 per share—representin

ICICI Securities has reaffirmed its BUY rating on Lupin Ltd, setting a target price of Rs 2,275, reflecting a 15% upside from the current market price of Rs 1,975.

Torrent Pharmaceuticals Ltd.